Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-07-27

Clinical Trial Update: Optimized Treatment and Regression of HBV-induced Early Cirrhosis [Phase 4]

View source ↗

Summary

Phase 4 trial update reports regression of HBV-related early liver cirrhosis with an optimized treatment approach.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Beijing Friendship Hospital | Conditions: Liver Cirrhosis | Phase 4 | Status: COMPLETED